Future longitudinal and multicenter studies with larger and demographically diverse RA cohorts, incorporating serial ISM1 measurements and comprehensive immunophenotyping, will be essential to validate our findings and to clarify the clinical relevance of ISM1 in RA. The gene discussed is ISM1; the disease is rheumatoid arthritis.